Abstract
Inbred strains of mice were found to differ markedly in both susceptibility to the spontaneous development of malignant alveologenic lung tumours and the ease with which these tumours could be induced with chemical carcinogens administered to adult animals. Malignant lung tumours occurred in normal strain A mice but were very rare in normal C3Hf, DBA/2 and C57BL/6 mice or in these mice treated as adults with the carcinogen 1-ethyl-1-nitrosourea (ENU). Malignant tumours could, however, be induced in C3Hf mice exposed prenatally to ENU. Two transplacentally induced malignant lung tumours of C3Hf mice failed to grow when transplanted to normal C3Hf recipients but did grow progressively when transplanted into either (C3Hf × A) F1 hybrid or C3H recipients. The tumours grew progressively in sublethally x-irradiated but otherwise untreated C3Hf mice. Immunization of C3Hf mice with either of the lung tumours, or with normal lung tissue of either A or C3H mice, induced a degree of radioresistant immunity such that tumour cells inoculated into immunized, sublethally x-irradiated mice, failed to grow progressively. Radioresistant immunity was not induced when C3Hf mice were immunized with lung tissue of DBA/2 or C57BL/6 mice. Lymphoid cells of (C3Hf × A) F1 and C3H mice bearing transplanted C3Hf lung tumour reacted against cultured lung tumour cells in the microcytotoxicity assay. Reactivity was also observed against cells cultured from normal lungs of C3H and (C3Hf × A) F1 mice but not against cells cultured from normal lungs of C3Hf or C57BL/6 mice. These results were interpreted to indicate that transplacentally induced malignant lung tumours of C3Hf mice express an antigenic component which exists as a normal tissue alloantigen, present in A and C3H but not in C3Hf, DBA/2 or C57BL/6 mice. It was suggested that the normal expression of the alloantigen in A mice may contribute to the susceptibility of these mice to the spontaneous development of lung tumours. The observation that a tumour bearing host has lymphoid cells reactive in the microcytotoxicity assay against tumour cells does not necessarily indicate that the tumour possesses a tumour specific antigen for in genetically susceptible tumour bearing hosts, the reaction may be directed against a self-antigen.
Full text
PDF













Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bansal S. C., Hellström K. E., Hellström I., Sjögren H. O. Cell-mediated immunity and blocking serum activity to tolerated allografts in rats. J Exp Med. 1973 Mar 1;137(3):590–602. doi: 10.1084/jem.137.3.590. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Basombrío M. A., Prehn R. T. Studies on the basis for diversity and time of appearance of antigens in chemically induced tumors. Natl Cancer Inst Monogr. 1972 Dec;35:117–124. [PubMed] [Google Scholar]
- DAY E. D. Animal cancer, the primary tool. Cancer Res. 1961 Jun;21:581–582. [PubMed] [Google Scholar]
- Hellström I., Hellström K. E., Allison A. C. Neonatally induced allograft tolerance may be mediated by serum-borne factors. Nature. 1971 Mar 5;230(5288):49–50. doi: 10.1038/230049a0. [DOI] [PubMed] [Google Scholar]
- Hellström I., Hellström K. E. Can "blocking" serum factors protect against autoimmunity? Nature. 1972 Dec 22;240(5382):471–473. doi: 10.1038/240471a0. [DOI] [PubMed] [Google Scholar]
- Hellström I., Hellström K. E., Sjögren H. O., Warner G. A. Demonstration of cell-mediated immunity to human neoplasms of various histological types. Int J Cancer. 1971 Jan 15;7(1):1–16. doi: 10.1002/ijc.2910070102. [DOI] [PubMed] [Google Scholar]
- Hellström I., Hellström K. E. Some recent studies on cellular immunity to human melanomas. Fed Proc. 1973 Feb;32(2):156–159. [PubMed] [Google Scholar]
- Hellström K. E., Hellström I., Brawn J. Abrogation of cellular immunity to antigenically foreign mouse embryonic cells by a serum factor. Nature. 1969 Nov 29;224(5222):914–915. doi: 10.1038/224914a0. [DOI] [PubMed] [Google Scholar]
- Herberman R. B., Aoki T. Immune and natural antibodies to syngeneic murine plasma cell tumors. J Exp Med. 1972 Jul 1;136(1):94–111. doi: 10.1084/jem.136.1.94. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Martin W. J., Esber E., Wunderlich J. R. Evidence for the suppression of the development of cytotoxic lymphoid cells in tumor immunized mice. Fed Proc. 1973 Feb;32(2):173–179. [PubMed] [Google Scholar]
- Mintz B., Custer R. P., Donnelly A. J. Genetic diseases and developmental defects analyzed in allophenic mice. Int Rev Exp Pathol. 1971;10:143–179. [PubMed] [Google Scholar]
- Old L. J., Boyse E. A., Stockert E. The G (Gross) leukemia antigen. Cancer Res. 1965 Jul;25(6):813–819. [PubMed] [Google Scholar]
- Riches A. C., Thomas D. B. The effects of x-irradiation and anti-lymphocyte serum on the responses to tumour allografts. Br J Cancer. 1970 Dec;24(4):833–842. doi: 10.1038/bjc.1970.98. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stockert E., Old L. J., Boyse E. A. The G-IX system. A cell surface allo-antigen associated with murine leukemia virus; implications regarding chromosomal integration of the viral genome. J Exp Med. 1971 Jun 1;133(6):1334–1355. doi: 10.1084/jem.133.6.1334. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wegmann T. G., Hellström I., Hellström K. E. Immunological tolerance: "forbidden clones" allowed in tetraparental mice. Proc Natl Acad Sci U S A. 1971 Jul;68(7):1644–1647. doi: 10.1073/pnas.68.7.1644. [DOI] [PMC free article] [PubMed] [Google Scholar]
